India’s first intranasal Covid vaccine by Bharat Biotech received DCGI approval on Tuesday for major immunization against the infection for human beings above the age of 18. Lauding the achievement, Health Minister Dr Mansukh Mandaviya said, it is a ‘Big Boost to India’s Fight Against COVID-19’.
Mandaviya tweeted, Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine permitted via @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for confined use in emergency situation.
